0
Fancy This: New Gourmet Nutrition Bar with Wellmune WGP Coming to Fancy Foods Show

Biothera customer ResVez, Inc. is debuting the first gourmet nutrition bar with Wellmune WGP at the Fancy Food Show January 15-17 in San Francisco. The TravelTime bar is available in a choice of Granola Citrus Burst or Almond Coffee with chocolate chips. In addition to containing Wellmune WGP to activate the immune system, TravelTime bars also include Resveratrol, the powerful antioxidant found in the skin of red grapes. Click here to learn more about this uniquely healthy snack good for anyone on the go or visit ResVez at Booth 363, North Hall, Moscone Center.

3

EAGAN, MN — September 13, 2011 — Wellmune WGP®, the immune health ingredient for foods, beverages and supplements from Biothera, has been named a recipient of a 2011 SupplySide West Scientific Excellence Award.

Virgo Publishing announced today that Wellmune WGP will be honored at an awards ceremony at 2:00 pm on Wednesday, October 12 in the Virgo booth (#22061) at SupplySide West in Las Vegas at The Venetian & Sands Expo.

A panel of industry experts evaluated award submissions on the basis of science/research methods, scientific breakthrough, innovation and appeal for the manufacturing community.  The Wellmune technology has been the subject of 30 peer-reviewed articles over the past decade, including six publications or scientific conference presentations of original clinical research in the 2010-2011.  In announcing Wellmune’s selection for an award this year, Virgo Publishing stated:  “All of these well-designed human clinical trials consistently demonstrated significant health benefits, including improved physical health, reduced upper respiratory track infection symptoms and improved well-being.”

“We are honored that Wellmune WGP has received this prestigious award,” said Rich Mueller, Biothera chief executive officer.  “This award is further recognition of Biothera’s strong commitment to an ongoing clinical research program that supports the use of Wellmune WGP as a unique food, beverage and supplement ingredient.”

Wellmune WGP has previously received an Innovation Award from the Institute of Food Technologists and a Frost & Sullivan Excellence in Research Award.

Virgo Publishing also stated:  “This technology has captured mainstream scientific community interest as evidenced by the April cover story in the journal Nature further elucidating the mechanism of action of Wellmune WGP. Additional knowledge of how Wellmune WGP works in the body was published in the June issue of the journal Blood, making Wellmune one of the best characterized and mechanistically understood ingredients in the natural products industry.”  Biothera’s research collaborations include leading institutions, such as UCLA medical center, Scripps Institute, Southampton University Hospital (UK), University of Louisville, Ohio State University, and University of Houston.

“Our team of chemists, biologists and immunologists have developed novel analytical methods and conducted numerous toxicology, mechanism of action and preclinical studies,” said Don Cox, Ph.D., senior vice president, Biothera research and development.  “We also have a large number of active research collaborations that have also further advanced the science of
 Wellmune WGP.”

About Wellmune WGP
Wellmune WGP is a natural ingredient that is clinically proven to safely prime the immune system to keep the body healthy. Wellmune WGP is a proprietary baker’s yeast beta glucan that mobilizes billions of innate immune cells that are part of the body’s natural defenses.  This unique immune health ingredient helps increase their effectiveness without stimulating the immune system. Wellmune WGP is Generally Recognized as Safe (GRAS) under U.S. FDA regulations and has broad regulatory approval worldwide.  It is also patented, Kosher, Halal, non-allergenic, GMO-free.  Wellmune WGP is an ingredient in products in more than 30 countries.

About Biothera, the immune health company
Biothera is a biotechnology company dedicated to improving immune health. The company’s Healthcare Group is a leading provider of natural immune health ingredients for the functional food and beverage, dietary supplement, cosmetic and animal nutrition markets.  Biothera’s flagship ingredient is Wellmune WGP, a unique food, beverage and supplement ingredient.

Contact:
David Walsh
VP Communications
Biothera, the Immune Health Company
651-256-4606
dwalsh@biothera.com

 

0

Biothera Analytical Methods Adopted for New Industry Standard

EAGAN, MN — September 8, 2011 — The United States Pharmacopeia (USP), in collaboration with Biothera, has developed the first official monograph for beta glucan from bakers yeast (Saccharomyces Cerevisiae), a natural food, beverage and dietary supplement ingredient widely recognized for its immune health benefits.

The monograph was recently issued in the Third Supplement of the Seventh Edition of the Food Chemicals Codex, an internationally recognized compendium of standards for the purity and identity of food ingredients.

Biothera is a biotechnology company dedicated to improving immune health.  The company manufactures Wellmune WGP®, a proprietary bakers yeast beta glucan clinically proven to prime key immune cells that help keep the body healthy and vital.  Biothera contributed the reference standard and two methods for identifying and quantifying the beta 1,3/1,6 branched glucan polymer derived from the cell walls of bakers yeast.

The Biothera identification method uses Nuclear Magnetic Resonance Spectroscopy to detect glucan branch linkages.  To quantify the purity of the beta glucan content, Biothera developed the Glucan Enzymatic Method (GEM™) Assay that was recently published in the ACS Journal of Agricultural and Food Chemistry.

“Biothera is pleased to share its expertise in carbohydrate chemistry to help set the industry standard for characterizing and analyzing beta glucan from bakers yeast,” said Rich Mueller, Biothera chief executive officer.

“We are pleased the USP recognized the technical merit of our analytical methods, and validated and adopted our analytical methods as part of the new monograph,” said Andy Magee, Ph.D., Biothera vice president of Chemistry.

The USP Expert Committee approved the proposed monographs after being published in Pharmacopeial Forum for public comment.  USP sets standards for manufacturers to comply for products legally marketed in the U.S. These monographs address quality, identification, labeling, purity, and potency, among other tests. All beta glucans from bakers yeast must fulfill the requirements of the USP monographs, at a minimum. The monographs will facilitate FDA’s determination of compliance of the marketed products to these public standards.

USP—Advancing Public Health Since 1820
The United States Pharmacopeia (USP) is a nonprofit, nongovernmental, standards-setting organization that advances public health by ensuring the quality and consistency of medicines, promoting the safe and proper use of medications, and verifying ingredients in dietary supplements. These standards, which are recognized worldwide, are developed by a unique process of public involvement through the contributions of volunteers representing pharmacy, medicine, and other health care professions, as well as science, academia, government, the pharmaceutical industry, and consumer organizations.

About Biothera, the immune health company
Biothera is a biotechnology company dedicated to improving immune health. The company’s Healthcare Group is a leading provider of natural immune health ingredients for the functional food and beverage, dietary supplement, cosmetic and animal nutrition markets.  Biothera’s flagship ingredient is Wellmune WGP, a unique food, beverage and supplement ingredient that is Generally Recognized as Safe (GRAS) under U.S. FDA regulations.  It is also patented, Kosher, Halal, non-allergenic and GMO-free. The ingredient is recipient of an IFT Innovation Award and a Frost & Sullivan Excellence in Research Award.

Contact:
David Walsh
VP Communications
Biothera, the Immune Health Company
651-256-4606
dwalsh@biothera.com

 

0

EAGAN, MN — September 3, 2011 — Biothera, the manufacturer of Wellmune WGP,  will sponsor a webinar about the link between stress and numerous health problems, including suppression of the immune system, at 1:00 pm U.S. central standard time on Wednesday, September 14. The webinar will be hosted on FoodNavigator-USA.com and NutraIngredients-USA.com.  Register here.

The webinar is entitled, “Closing the Window on Stress-Related Immune Suppression,” and features distinguished panelists in the fields of natural medicine, exercise physiology and immunology and immune health ingredient research will discuss their research and what it may mean to manufacturers of foods, beverages and supplements.

Surveys show that 75% of Americans today say they are “stressed out” and that stress is a major factor in workplace absenteeism and lost productivity. “Our industry has a tremendous opportunity to develop products that can deliver real immune health benefits to consumers so they can better cope with the daily stresses of their lives,” said Richard Mueller, president of Biothera’s Healthcare Group.

The webinar panel will include three industry experts:

Michael T. Murray, N.D.
Chairman, Dr. Murray Natural Living, Inc.

Brian McFarlin, Ph.D., FACSM
Associate Professor of Exercise Physiology, Nutrition and Immunology
Department of Health and Human Performance
University of Houston

Don Cox, Ph.D. 
Senior Vice President, Research & Development
Biothera, the immune health company

For more information, contact:
David Walsh
Vice President, Communication
Biothera
651-256-4606
dwalsh@biothera.com

 



					
				
				
0

Clinical Study Conducted by University of Houston

Results Presented at International Society of Exercise Immunology

EAGAN, MN — July 11, 2011 — A new clinical study indicates that Wellmune WGP®, a natural functional food ingredient, may enable both recreational and elite athletes to exercise longer and harder with less risk of immune system suppression that normally occurs following high intensity exercise.

The effectiveness of the immune system drops sharply below its normal state two to six hours after strenuous exercise and then gradually recovers within 24 hours.  “During this ‘open window’ period, the athlete is more susceptible to infection, which may result in lost training time as well as missed work or school,” said Brian McFarlin, Ph.D., FACSM, Associate Professor of Exercise Physiology, Nutrition, and Immunology in the Department of Health and Human Performance at the University of Houston.

Dr. McFarlin conducted the research that demonstrated that Wellmune WGP not only reduced the “open window” effect, but actually resulted in a higher level of immune responsiveness than the study subjects’ normal immune state.  “Wellmune provided a greater degree of protection before and after exercise, as measured by monocyte concentrations and certain protective cytokine levels,” said Dr. McFarlin.

“Wellmune WGP may enable athletes to maintain a strenuous training program, avoid down time and ultimately enhance their overall athletic performance,” said Dr. McFarlin.

The research was presented today at the International Society of Exercise Immunology’s symposium on “Exercise and Immunity in Athletic Performance and a Healthy Life” at St. Catherine’s College, University of Oxford, United Kingdom.  The research poster presentation is entitled, “The Effects of Yeast β-glucan Supplementation on Monocytes and Cytokine Response to Exercise.”

Study Design
The randomized, double-blinded, placebo-controlled study involved 60 recreational athletes [31 women (age 22 +5), 29 men (age 23 +5)] engaged in sustained aerobic exercise.  Following initial screening, study subjects were given either a placebo or 250 mg of Wellmune WGP daily for 10 days.

At the end of the period, the athletes rode an exercise bicycle for approximately one hour in the heat stress chamber at the Health and Human Performance lab at the University of Houston.  Exercise conditions in the chamber were set at 38C (100F) and 45% relative humidity to create an environment that placed the athletes under physiological and psychological stress.  The athletes were closely monitored during the exercise challenge to ensure their safety.  Blood samples were drawn at day 0 and immediately before and after the exercise session and again two hours post exercise.  The samples were analyzed for 25 immune system measurements.

Using a cross-over study design, the athletes next observed an eight-day “wash out” period during which no supplement was given to clear their bodies of any supplement effect.  The study subjects then repeated the 10-day supplementation with the other test variable (Wellmune or placebo).  At the end of the second supplementation period, the subjects then replicated their initial exercise regimen.

Study Results
Study subjects taking Wellmune WGP had statistically significant higher concentrations of monocytes in their blood compared with the blood samples while taking the placebo.  The higher monocyte level was recorded immediately before and after exercise, as well as two hours post exercise.

Study participants also had higher levels of key cytokines (IL-2, IL-4, IL-5 and IFN gamma) following Lipopolysaccharide (LPS) stimulation when taking Wellmune WGP.  LPS is derived from gram-negative bacteria and used to mimic a foreign challenge to stimulate an immune response.  The data also showed higher levels of plasma cytokines (IL-4, IL-5, IL-7, IL-8, IL-10 and IFN gamma) two hours after exercise when the subjects had supplemented with Wellmune.  All of these results were statistically significant (p<0.05).

“The effect of Wellmune WGP on LPS-stimulated IL-4 and IL-5 production suggests that leukocytes were primed for higher plasma cytokines that directly mediate innate and humoral dependent immune responses” said Dr. McFarlin.  “Our lab has tested numerous compounds but Wellmune is the first to prevent alterations in monocyte and key cytokines following high intensity exercise.”

“These study results are not surprising given the beneficial effects of Wellmune WGP demonstrated in previous clinical trials involving marathoner runners, wildland fire fighters and individuals with high stress lifestyles,” said Don Cox, Ph.D., senior vice president, research and development, for Biothera, the manufacturer of Wellmune WGP.

About Wellmune WGP
Wellmune WGP is a natural carbohydrate that is clinically proven to prime key immune cells that keep the body healthy.  This unique food, beverage and supplement ingredient is Generally Recognized as Safe (GRAS) under U.S. FDA regulations.  It is also patented, Kosher, Halal, non-allergenic and GMO-free. The ingredient is recipient of an IFT Innovation Award and a Frost & Sullivan Excellence in Research Award. Wellmune WGP is a product of Biothera, a U.S. biotechnology company dedicated to improving immune health.

About the University of Houston
The University of Houston is a Carnegie-designated Tier One public research university recognized by The Princeton Review as one of the nation’s best colleges for undergraduate education. UH serves the globally competitive Houston and Gulf Coast Region by providing world-class faculty, experiential learning and strategic Industry partnerships. Located in the nation’s fourth-largest city, UH serves more than 38,500 students in the most ethnically and culturally diverse region in the country.

Contact:
David Walsh
VP Communications
Biothera, the Immune Health Company
651-256-4606 (direct)
dwalsh@biothera.com

 

 

0

EAGAN, MN — May 24, 2011 — Biothera will showcase Wellmune WGP®, the company’s clinically proven immune health ingredient for foods, beverages and supplements, at the Institute of Food Technologists (IFT) annual meeting and food expo June 11-14 in New Orleans. The Wellmune WGP display (#7547) will feature numerous products containing Wellmune WGP, educational videos and an opportunity to speak with Biothera scientists and sales people.

This year visitors can sample the following products containing  Wellmune WGP:

  • Healthy Praeventia cookies and bars from Groupe Biscuits Leclerc Ltd.
  • Healthyshot®, an immune-enhancing powder stick packs from Diamond Crystal Brands.

About Wellmune WGP
Wellmune WGP is a natural ingredient derived from the cell wall of a proprietary strain of baker’s yeast (Saccharomyces cerevisiae).  Wellmune WGP is patented, Kosher, Halal, non-allergenic and GMO-free.  The ingredient is recipient of an IFT Innovation Award and a Frost & Sullivan Excellence in Research Award. Wellmune WGP is a product of Biothera, a U.S. biotechnology company dedicated to improving immune health.  More information is available at www.wellmune.com or follow us on Facebook and Twitter.

Contact:
David Walsh
VP Communications
Biothera, the Immune Health Company
651-256-4606 (direct)
dwalsh@biothera.com

 

0

EAGAN, MN — May 11, 2011 — The European Food Safety Authority (EFSA) Panel on Dietetic Products, Nutrition and Allergies has issued a positive scientific opinion on Wellmune WGP® as a novel food, Biothera, the manufacturer of Wellmune WGP, announced today.

Wellmune WGP would be the only yeast-derived beta glucan to receive the novel food designation and be permitted for use in foods, beverages and supplements in Europe.

Wellmune WGP is a natural ingredient that is clinically proven to safely prime the immune system to keep the body healthy.  Numerous peer-reviewed studies demonstrate that Wellmune WGP mobilizes billions of innate immune cells that are part of the body’s natural defenses without over stimulating the immune system.

“We are pleased with the finding of EFSA’s review of our clinical and safety data supporting Wellmune WGP,” said Richard Mueller, chief executive officer of Biothera.  “We have ongoing discussions with a number of companies about product concepts in anticipation of this opinion from EFSA.”

The novel food designation from EFSA will further expand worldwide regulatory approval of Wellmune WGP.  Food, beverage and supplement products containing Wellmune WGP are sold in more than 30 countries today.  Recently the China Ministry of Health also approved Wellmune WGP by giving the ingredient Novel Foods status.

Biothera’s European distribution partner is Immicare AB, based in Sweden.  Biothera also works with DKSH for distribution of its ingredients in Italy.  Contact information for Immicare AB and all Biothera distributors is available at http://www.wellmune.com/for-manufacturers/distribution/.

About Wellmune WGP
Wellmune WGP is a natural ingredient derived from the cell wall of a proprietary strain of baker’s yeast (Saccharomyces cerevisiae).  Wellmune WGP is patented, Kosher, Halal, non-allergenic and GMO-free.  The ingredient is recipient of an IFT Innovation Award and a Frost & Sullivan Excellence in Research Award. Wellmune WGP is a product of Biothera, a U.S. biotechnology company dedicated to improving immune health.  More information is available at www.wellmune.com or follow us on Facebook and Twitter.

Contact:
David Walsh
VP Communications
Biothera, the Immune Health Company
651-256-4606 (direct)
dwalsh@biothera.com

3

EAGAN, MN — April 27, 2011 — A new study published today as the cover story in the journal Nature features Biothera’s beta glucans and new discoveries about how these unique immunodulating compounds prime the innate immune system to protect the body.

This research confirmed that not all beta glucans are alike.  Researchers led by David Underhill, Ph.D. demonstrated that beta glucan size and molecular structure is critical to receptor binding and the resulting innate immune cell response.  Dr. Underhill and his research team found that specific beta glucan structures bind to a particular receptor (Dectin-1) while other beta glucans structures did not.

“This research demonstrates that the structure of beta glucans matters,” said William Grossman, M.D., Ph.D., Biothera senior vice president of Research & Development.  “Even slight molecular differences in beta glucans affect the signaling pathways used to induce different killing mechanisms.  These data expand on our previous research showing that some of our other beta glucan structures bind to CR3, inducing separate and unique mechanisms.”

The study shows that Dectin-1 distinguishes between direct microbial contact and detection of microbes at a distance, a distinction that enables effective microbial killing responses.  When bound to Biothera’s Wellmune WGP®, Dectin-1 signaling primed immune cells for phagocytosis, a mechanism used to recognize and destroy pathogens.

“This research was possible because of Biothera’s capability to isolate, modify and characterize these beta glucan compounds,” said Dr. Underhill, associate professor, IBD and Immunobiology Research Institute, Cedars-Sinai Medical Center.

Biothera is a U.S. biotechnology company that is pioneering beta glucan research.  The company has developed glucans as both pharmaceutical applications and immune health ingredients for foods, beverages and supplements.  The company’s Imprime PGG® is an injectable drug that is currently in a Phase III clinical trial for colorectal cancer and multiple Phase II trials for non small cell lung cancer.  Biothera’s Wellmune WGP® is a food-grade, immune-health ingredient for functional foods, beverages and supplements in more than 30 countries.

“We’re pleased to be able to contribute to the growing body of research surrounding beta glucan structures and their relationship to functional mechanisms,” said Don Cox, Ph.D., senior vice president, Biothera Healthcare Research & Development.

The title of the Nature paper is “Activation of the Innate Immune Receptor Dectin-1 upon Formation of a ‘Phagocytic Synapse.’” The paper is accessible on the Nature website.

About Biothera, the Immune Health Company
Biothera is a biotechnology company dedicated to improving immune health. The company is commercializing its unique technology platform through two business groups. Biothera’s Pharmaceutical Group is conducting multiple clinical trials for the development of an immune modulating drug that mobilizes the innate immune system to fight most types of cancer. The company’s Healthcare Group is a leading provider of natural immune health ingredients for the functional food and beverage, dietary supplement, cosmetic and animal nutrition markets.

Contact:
David Walsh
VP Communications
Biothera, the Immune Health Company
651-256-4606 (direct)
dwalsh@biothera.com

1

HealthyshotEAGAN, MN — April 20, 2011 — Hormel Health Labs, a division of Diamond Crystal Brandshas expanded its line of HealthyShot® Wellness Products to include several powdered beverages containing Wellmune WGP®, the natural immune health ingredient from Biothera.

The products combine the convenience of powdered beverages and the clinically proven immune support of Wellmune WGP.  Available in three flavors: Lemonade, Pomegranate-Cherry and Raspberry- Green Tea, they are convenient, great tasting and provide a strong immune system message. [...]

0

EAGAN, MN — April 18, 2011 — Biothera achieved a “Superior” rating in its recent independent AIB International audit of the company’s Good Manufacturing Practices (cGMP) at its distribution center in Eagan, Minnesota.  The AIB food safety and hygiene standard is one of the strictest standards in the world. [...]

.